| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/23/2009 | CN101537170A Compound for preventing osteoporosis and osteoarthrosis |
| 09/23/2009 | CN101537169A Transfer factor solution for livestock and poultry, and preparation method thereof |
| 09/23/2009 | CN101536987A Sodium alginate microballoon vein suppository containing hemangioma-resisting medicant, preparation method and application thereof |
| 09/23/2009 | CN101536984A Injection-use recombinant human Endostatin porous sustained-release microsphere and preparation method thereof |
| 09/23/2009 | CN101536982A Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof |
| 09/23/2009 | CN100543137C Novel forms of interfering RNA molecules |
| 09/23/2009 | CN100543036C Targeting proteins to deliver therapeutic or diagnostic reagents |
| 09/23/2009 | CN100543032C Streptogramin derivatives, preparation and compositions containing them |
| 09/23/2009 | CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 09/23/2009 | CN100542612C Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 09/23/2009 | CN100542604C Brain-caring compound tablet, its preparation process and quality control method |
| 09/23/2009 | CN100542603C Preparation technology of muscular amino acids and peptides and nucleoside injection liquid |
| 09/23/2009 | CN100542602C Preparation technology of liver hydrolytic peptide injection liquid |
| 09/23/2009 | CN100542542C Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| 09/22/2009 | US7593817 Calculating confidence levels for peptide and protein identification |
| 09/22/2009 | US7592503 Producing transgenic animals for obtaining useful proteins; combining genome from activated donor cell with activated, enucleated oocyte to form nuclear transfer embryo for impregnation |
| 09/22/2009 | US7592438 Human gene |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592428 monoclonal antibodies binds specifically to the extracellular domain; useful in diagnostic methods, enzyme-linked immunosorbent assay; use in therapy to modulate activin or transforming growth factor activity; biodrugs for fibrosis, liver cirrhosis and pulmonary fibrosis, cancer, rheumatoid arthritis |
| 09/22/2009 | US7592426 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
| 09/22/2009 | US7592425 antibody binds a polypeptide; use in tissue targeted therapy; Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo; polypeptide-toxins |
| 09/22/2009 | US7592423 Globular adiponectin variants |
| 09/22/2009 | US7592422 Modified plasminogen activator inhibitor type-1 and methods based thereon |
| 09/22/2009 | US7592421 antigens, immunogens for therapy of Non-Hodgkins Lymphoma diseases; using the peptides to elicit an immune response against human leukocyte antigen class II antigen; autoimmune diseases; biodrugs |
| 09/22/2009 | US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 09/22/2009 | US7592327 Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils |
| 09/22/2009 | US7592323 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/22/2009 | US7592319 Protein kinase (PK); for increasing the susceptibility of a cell to DNA-damaging agents via hybridization of nucleic acids encoding DNA dependent protein kinases, preventing gene expression; genetic engineering |
| 09/22/2009 | US7592318 88kDa tumorigenic growth factor and antagonists |
| 09/22/2009 | US7592316 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/22/2009 | US7592315 Peptide viral entry inhibitors |
| 09/22/2009 | US7592314 Use of VEGF and homologues to treat neuron disorders |
| 09/22/2009 | US7592313 Method of stimulating proliferation of regulatory T cells in a diabetic mammal |
| 09/22/2009 | US7592312 Methods of modulating gastrointestinal contractility |
| 09/22/2009 | US7592311 Platelet production promoting agent |
| 09/22/2009 | US7592310 Induction of antibiotic proteins and peptides by LAIT/sCD14-protein |
| 09/22/2009 | US7592309 Method of using a peptide having analgesic and antitumor activity from scorpion |
| 09/22/2009 | US7592308 F3W variants of the lantibiotic mersacidin and its use |
| 09/22/2009 | US7592307 Releasable linkage and compositions containing same |
| 09/22/2009 | US7592306 Reducing immune response against mismatched transplanted organs such as kidney, heart, lung, liver, pancreas, bone marrow and peripheral stem cells |
| 09/22/2009 | US7592305 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 09/22/2009 | US7592304 Metal-binding compounds and uses therefor |
| 09/22/2009 | US7592188 Live cell biosensors |
| 09/22/2009 | US7592152 Chondroitinase ABC I and methods of analyzing therewith |
| 09/22/2009 | US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 09/22/2009 | US7592143 Induction of capacse cascade ; administering apoptosis inducing protein; drug screening; anticancer agents |
| 09/22/2009 | US7592140 2′, 5′-oligoadenylate phosphodiesterase |
| 09/22/2009 | US7592023 Transplant media |
| 09/22/2009 | US7592013 Administering a recombant food-grade bacterium expressing a trefoil peptide;delivering a TFF1 trefoil peptide in vivo expressed by a Lactococcus for lesion damage to the mucous membranes of the mouth caused by radiation; antinflammatory agents; gastrointestinal disorders |
| 09/22/2009 | US7592012 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 09/22/2009 | US7592011 Streptococcal peptide for use in prevention and treatment of microorganismal infection; bactericides; microbiocides |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7592009 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 09/22/2009 | US7592008 Membrane scaffold proteins |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | US7592006 Composition comprising the LO-CD2a antibody |
| 09/22/2009 | US7591999 An active material, a nonwater-absorbant, hardly water-soluble cellulose and a mucolytic cysteine derivative; aqueous ethanol/insulin solution, ethyl cellulose, N-acetylcysteine; inproved absorption, permeability of the physiologically active substance at a nasal mucous membrane; side effect reduction |
| 09/22/2009 | US7591997 Method for determining the susceptibility of a subject to infection |
| 09/22/2009 | US7591996 Selectively mechanically damaging endothelial cells in a blood vessel to develop a fibrin clot; using a catheter to deliver contrast agent; focusing acoustical energy to induce cavitation in the ultrasound contrast agent without damaginge thermally proximate tissue; sclerotherapy; hemostatic agent; |
| 09/22/2009 | US7591841 Implantable devices for accelerated healing |
| 09/22/2009 | CA2395709C Process for the preparation of micronised collagen, and its therapeutic applications |
| 09/22/2009 | CA2369451C Composition based on oppositely-charged polypeptides |
| 09/22/2009 | CA2335308C Protease containing hairball remedy and use thereof |
| 09/22/2009 | CA2295957C Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy |
| 09/22/2009 | CA2223703C Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 09/22/2009 | CA2200980C Mammalian receptors for modified low-density lipoprotein |
| 09/22/2009 | CA2191827C Protein which binds atp and nucleic acid and which possesses putative helicase and atpase properties |
| 09/22/2009 | CA2188816C Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein |
| 09/17/2009 | WO2009114878A2 Methods and compositions for genetic and retinal disease |
| 09/17/2009 | WO2009114869A2 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis |
| 09/17/2009 | WO2009114831A2 Process to produce fibrillar proteins and method of treating using fibrillar proteins |
| 09/17/2009 | WO2009114826A2 Treatment systems and methods for renal-related diseases |
| 09/17/2009 | WO2009114757A2 A novel pharmaceutical preparation for preeclampsia, eclampsia, and toxemia and their related symptoms and related disorders of pregnancy |
| 09/17/2009 | WO2009114719A2 Apparatus and method of retaining and releasing molecules from nanostructures by an external stimulus |
| 09/17/2009 | WO2009114623A2 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | WO2009114597A1 Apoaequorin-containing compositions and methods of using same |
| 09/17/2009 | WO2009114539A2 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments |
| 09/17/2009 | WO2009114520A2 Compositions for treatment with metallopeptidases, methods of making and using the same |
| 09/17/2009 | WO2009114462A2 Local delivery of chemotherapeutic agents to skeletal metastases |
| 09/17/2009 | WO2009114461A2 Angiotensin (1-7) dosage forms and uses thereof |
| 09/17/2009 | WO2009114197A2 Reactivation of axon growth and recovery in chronic spinal cord injury |
| 09/17/2009 | WO2009113965A1 Isthmin derivatives for use in treating angiogenesis |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113661A1 Cyclic compound and salt thereof |
| 09/17/2009 | WO2009113660A1 Microorganism producing cyclic compound |
| 09/17/2009 | WO2009113480A1 Therapeutic agent for cerebral infarction |
| 09/17/2009 | WO2009113464A1 Anti-influenza virus composition and food for preventing influenza |
| 09/17/2009 | WO2009113074A1 Novel gp96 derived peptides |
| 09/17/2009 | WO2009112831A1 Immunotherapeutic methods and molecules |
| 09/17/2009 | WO2009112645A1 Peptide for activating aquaporin synthesis |
| 09/17/2009 | WO2009112609A1 Novel uses of sodium 4-phenylbutyrate (4 pba) and the pharmaceutically acceptable salts thereof |
| 09/17/2009 | WO2009112583A2 Protease-stabilized insulin analogues |
| 09/17/2009 | WO2009112536A1 Treating cancer |
| 09/17/2009 | WO2009112508A1 A method for the production of a human protein in a plant, in particular a human recombinant lysosomal enzyme in a cereal endosperm |
| 09/17/2009 | WO2009111906A1 Beta sheet inhibiting peptides for preventing and/or treating alzheimer's disease |
| 09/17/2009 | WO2009111889A1 Lymphocyte control of obesity and insulin resistance |
| 09/17/2009 | WO2009111838A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | WO2009093189A3 Peptides, compositions, and uses thereof |
| 09/17/2009 | WO2009092806A3 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 09/17/2009 | WO2009086202A3 Methods for treating neuropsychiatric conditions |